Journal of Laboratory Medicine and Quality Assurance

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2288-7261   pISSN 2384-2458

Table. 3.

Table. 3.

Effects on hemolysis according to infusion rates

Infusion rate (mL/hr)BaselineTerumo–post infusionBaxter–post infusion



Plasma Hb (mg/dL)%Hemolysis (%)Plasma Hb (mg/dL)%Hemolysis (%)Plasma Hb (mg/dL)%Hemolysis (%)
1025.4±5.190.09±0.0041.8±13.630.15±0.0158.2±20.130.22±0.03
3025.9±6.220.07±0.0134.0±12.020.10±0.0239.1±12.980.11±0.03
10046.9±17.50.14±0.0656.3±11.310.16±0.0465.2±9.750.19±0.04

Values are presented as mean±standard deviation. Each number represents an average value of three samples. The instruments were from the following companies: Baxter Healthcare Corp. (Deerfield, IL, USA) and Terumo Medical Corp. (Tokyo, Japan).

Abbreviation: Hb, hemoglobin.

J Lab Med Qual Assur 2019;41:161-5 https://doi.org/10.15263/jlmqa.2019.41.3.161
© 2019 J Lab Med Qual Assur